feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Vivo X300 series launched India

trending

Divided Fed lowers rates

trending

Mbappe in Real Madrid UCL

trending

Gvardiol: City wary of rivals

trending

Spotify Premium expands video access

trending

Major Mohit Sharma biopic dispute

trending

Kohli displaces Daryl Mitchell

trending

AI driving RAM prices up

trending

Thailand beats Singapore; Indonesia advances

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Rabies Test Breakthrough: Cheaper, Safer Immunity Check

Rabies Test Breakthrough: Cheaper, Safer Immunity Check

22 Nov

•

Summary

  • New assay detects rabies antibodies safely and affordably.
  • Test confirms immunity levels after vaccination with high accuracy.
  • IAV offers public access to the novel rabies antibody test for ₹500.
Rabies Test Breakthrough: Cheaper, Safer Immunity Check

A groundbreaking, safer, and more affordable assay for detecting rabies antibodies has been developed by the Institute of Advanced Virology (IAV). This novel test accurately confirms immunity levels following vaccination, overcoming the limitations of older, more complex methods that required live virus handling.

The Institute of Advanced Virology's new pseudovirus-based assay offers high throughput and lower costs, making large-scale immune response surveillance feasible, especially in rabies-endemic regions. The test has proven effective for both human and animal rabies vaccination efficacy analysis.

This advancement aims to expand public health accessibility to anti-rabies antibody testing, contributing significantly to global rabies control. For ₹500 per sample, this test is crucial for verifying protective immunity in high-risk groups and ensuring the efficacy of rabies immunisation programs.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
IAV has created a new, safer assay using pseudoviruses to detect rabies neutralizing antibodies in vaccinated individuals and animals.
The new test is simpler, has high throughput, is less costly, and safer to perform than older methods like RFFIT and FAVN.
The Institute of Advanced Virology is offering the new rabies antibody test to the public at ₹500 per sample.

Read more news on

Healthside-arrow

You may also like

Hope for Nipah Virus: Vaccine Trials Begin in Bangladesh

1 day ago • 35 reads

article image

Bird Flu's Fever-Proof Secret Revealed

28 Nov • 199 reads

article image

Scottish Toddlers' Development Dips During Lockdown

26 Nov • 84 reads

article image

COVID Tech Fights Snakebite Damage

24 Nov • 78 reads

article image

Harvard Study Uncovers 8 Distinct Long Covid Patient Groups

24 Nov • 97 reads

article image